Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
This study shows how knowledge-intensive services activities (KISAs) contribute to the acquisition and growth capabilities of firms and public sector organisations.
This book presents case studies on innovation policy governance in Australia, Austria, Belgium (Flanders), Finland, Greece, Ireland, Japan, Korea, Netherlands, New Zealand, Norway and Sweden. It provides fresh insight into how governments are striving to make innovation policy more coherent.
English, , 19kb
This note summarises recent developments in science, technology and innovation in Japan.
Investment in information technologies has by no means been confined to the United States and yet, average European or Japanese growth experience has been quite different.